Summary
It has been reported that during chronic treatment with digitalis, the number of digitalis binding sites is increased in human erythrocytes [22]. From this finding a tachyphylaxis for cardiac glycosides has been postulated. We reinvestigated this problem in several groups of patients.
The number of3H-ouabain binding sites per erythrocyte in control persons (group I) was 214±60,n=43 (x±SD). The dissociation constant (KD) was 1.8±0.5 nM. Thirteen patients (group II) taking cardiac glycosides only, for at least 6 months, had 281±99 (p<0.05) ouabain binding sites per single red cell, KD=1.8±0.7 nM. Group III (34 patients) took digitalis for more than 6 months and diuretics for at least 3 months (352±126 (p<0.001), KD=1.6±0.6). Twenty-three of these (group IV) were taking a combination with “K+-saving” diuretics (336±194 (p<0.01), KD=1.6±0.5) and (group V, 11 patients) a combination with “K+-losing” diuretics (462±133 (p<0.001), KD=1.4±0.4). Nine patients (group VI) had a chronic hypokalemia, mainly due to taking furosemide (437±98 (p<0.001), KD=1.5±0.4). Four control persons took 50 mg hydrochlorothiazide daily for more than 4 months without measurable K+-losses and without changes in ouabain binding sites.
It is concluded from these findings that diuretic treatment with chronic hypokalemia in addition to digitalis is accompanied by a significant increase in ouabain binding sites in human red cells. Although the difference between control persons and those taking cardiac glycosides only, is statistically significant (p<0.05), the biological relevance is questionable because of considerable overlap of the values. Receptor affinity was unchanged under all circumstances. A change in the number of ouabain binding sites — if occurring also in the heart — may go along with an altered digitalis sensitivity.
Similar content being viewed by others
References
Aronson JK, Ford AR, Grahame-Smith DG (1981) Techniques for studying the pharmacodynamic effects of cardiac glycosides on patients' own erythrocytes during glycoside therapy. Klin Wochenschr 39:1323–1332
Astrup J (1974) The effect of hypokalemia and of digoxin therapy on red cell sodium and potassium content. Scand J Clin Lab Invest 33:11–16
Bluschke V, Bonn R, Greeff K (1976) Increase in the (Na++K+)-ATPase activity in heart muscle after chronic treatment with digitoxin or potassium deficient diet. Eur J Pharmacol 37:189–191
Bodemann HH (1981) Das Problem des zellulären Herzglykosidrezeptors. Klin Wochenschr 59:1333–1343
Bolte H-D, Lüderitz B, Erdmann E (1971) Intra-extracellular potassium gradients and resting membrane potential in potassium deficiency. Actual Pathol Neuromuscul 613–618
Bonn R, Greeff K (1978) The effect of chronic administration of digitoxin on the activity of the myocardial (Na++K+)-ATPase in guinea pigs. Arch Int Pharmacodyn Ther 233:53–64
Bossaller C, Schober O (1982) Increased number of red cell ouabain binding sites in diseases with chronic potassium depletion. Naunyn-Schmiedeberg's Arch Pharmacol 319:R43
Burck HC, Haasis R, Larbig D (1975) Beeinflußung der Erythrocyten-Elektrolyte durch β-Methyl-Digoxin bei Gesunden. Klin Wochenschr 53:125–128
Chan PC, Sanslone WR (1969) The influence of a lowpotassium diet on rat-erythrocyte-membrane adenosine triphosphatase. Arch Biochem Biophys 134:48–52
Cumberbatch M, Zareian K, Davidson C, Morgan DB, Swaminathan R (1981) The early and late effects of digoxin treatment on the sodium transport, sodium content and Na+K+-ATPase of erythrocytes. Br J Clin Pharmacol 11:565–570
Cumberbatch M, Morgan DB (1983) Erythrocyte sodium and potassium in patients with hypokalemia. Clin Sci 64:167–176
Erdmann E, Bolte H-D, Lüderitz B (1971) The (Na++K+)-ATPase activity of guinea pig heart muscle in potassium deficiency. Arch Biochem Biophys 145:121–125
Erdmann E, Hasse W (1975) Quantitative aspects of ouabain binding to human erythrocytes and cardiac membranes. J Physiol (Lond) 251:671–682
Erdmann E, Presek P, Swozil R (1976) Über den Einfluß von Kalium auf die Bindung von Strophanthin an menschlichen Herzmuskelzellmembranen. Klin Wochenschr 54:383–387
Erdmann E, Krawietz W (1977) Increased number of ouabain binding sites in human erythrocyte membranes in chronic hypokalemia. Acta Biol Med Ger 36:879–883
Erdmann E, Krawietz W, Koch M (1979) The number of ouabain binding sites in human erythrocytes is subject to regulation. In: Skou JC, Nørby JG (eds) Na,K-ATPase, structure and kinetics. Academic Press, London New York San Francisco, pp 517–524
Erdmann E (1981) Influence of cardiac glycosides on their receptor. In: Greeff K (ed) Handbuch für Experimentelle Pharmakologie, vol 56/I. Springer, Berlin Heidelberg, pp 337–380
Erdmann E (1982) Binding studies with3H-ouabain to red cell membranes. In: Ellory JC, Young JD (eds) Red cell membranes — a methodological approach. Academic Press, London New York San Francisco, pp 251–262
Erdmann E, Krawietz W, Werdan K (1983) Gibt es Rezeptveränderungen unter Langzeiteinwirkung von Digitalis? In: Gillmann H, Storstein L (Hrsg) Digitalis-Therapie heute. Verlag für angewandte Wissenschaften München, S 5–9
Ford AR, Aronson JK, Graham-Smith DG, Rose JA (1979) The characteristics of the binding of 12-α-3H-digoxin to the membranes of intact human erythrocytes: Relevance to digoxin therapy. Br J Clin Pharmacol 8:115–124
Ford AR, Aronson JK, Graham-Smith DG, Carver JG (1979) Changes in cardiac glycoside receptor sites,86Rb+-uptake and intracellular sodium concentrations in the erythrocytes of patients receiving digoxin during the early phases of treatment of cardiac failure in regular rhythm and of atrial fibrillation. Br J Clin Pharmacol 8:125–134
Ford AR, Aronson JK, Graham-Smith DG, Carver JG (1979) The acute changes seen in cardiac glycoside receptor sites,86Rb-uptake and intracellular sodium concentrations in the erythrocytes of patients during the early phases of digoxin therapy are not found during chronic therapy: Pharmacological and therapeutic implications for chronic digoxin therapy. Br J Clin Pharmacol 8:135–142
Knox WH, Sen AK (1974) Mechanism of action of aldosterone with particular reference to (Na+K)-ATPase. Ann NY Acad Sci 242:471–487
Ku DD, Akera T, Brody TM, Weaver LC (1977) Chronic digoxin treatment on canine myocardial Na+, K+-ATPase. Naunyn-Schmiedeberg's Arch Pharmacol 301:39–47
Loes MW, Singh S, Lock JE, Mirkin BL (1978) Relation between plasma and red-cell electrolyte concentrations and digoxin levels in children. N Engl J Med 299:501–504
Nørgaard A, Kjeldsen K, Clausen T (1981) Potassium depletion decreases the number of3H-ouabain binding sites and the active Na-K transport in skelatal muscle. Nature 293:739–741
Nørgaard A, Kjeldsen K, Hansen O, Clausen T (1983) A simple and rapid method for the determination of the number of3H-ouabain binding sites in biopsies of skeletal muscle. Biochem Biophys Res Commun 111:319–325
Rubython EI, Morgan DB (1983) Effect of hypokalemia on the ouabain-sensitive sodium transport and the ouabainbinding capacity in human erythrocytes. Clin Sci 64:177–182
Skou JC (1965) Enzymatic basis for active transport of Na+ and K+ across cell membrane. Rev Physiol 45:596–617
Ward JPT, Cameron IR (1980) Potassium homeostasis in cardiac muscle during chronic potassium depletion. J Molec Cell Cardiol 12:177
Author information
Authors and Affiliations
Additional information
Supported by the DFG (Er 65/4-3)
Rights and permissions
About this article
Cite this article
Erdmann, E., Werdan, K. & Krawietz, W. Influence of digitalis and diuretics on ouabain binding sites on human erythrocytes. Klin Wochenschr 62, 87–92 (1984). https://doi.org/10.1007/BF01769668
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01769668